Evaluating the Efficacy of Providers’ Compensation Contracts in Improving Participant Retention for Clinical Studies

References

• AbbVie (2022) Abbvie clinical pharmacology research unit. Accessed February 5, 2026, https://www.abbviephase1.com/.Google Scholar
• Adida E, Bravo F (2019) Contracts for healthcare referral services: Coordination via outcome-based penalty contracts. Management Sci. 65(3):1322–1341.Link, Google Scholar
• Ahuja V, Birge JR (2020) An approximation approach for response-adaptive clinical trial design. INFORMS J. Comput. 32(4):877–894.Abstract, Google Scholar
• Alban A, Chick SE, Forster M (2023) Value-based clinical trials: Selecting recruitment rates and trial lengths in different regulatory contexts. Management Sci. 69(6):3516–3535.Link, Google Scholar
• Anderer A, Bastani H, Silberholz J (2022) Adaptive clinical trial designs with surrogates: When should we bother? Management Sci. 68(3):1982–2002.Link, Google Scholar
• Andritsos DA, Tang CS (2018) Incentive programs for reducing readmissions when patient care is co-produced. Production Oper. Management 27(6):999–1020.Crossref, Google Scholar
• Arora V (2019) Inpatient sleep loss: Educating and empowering patients (ISLEEP). Accessed February 5, 2026, https://www.clinicaltrials.gov/ct2/show/NCT04151251.Google Scholar
• Ashton T (2023) A primer on the importance of recruitment and retention in clinical trials. Accessed February 5, 2026, https://acrpnet.org/2023/04/18/a-primer-on-the-importance-of-recruitment-and-retention-in-clinical-trials.Google Scholar
• Atsawasuwan P (2020) Gingival crevicular fluid characterization during orthodontic treatment. Identifier NCT04226469, Accessed February 5, 2026, https://clinicaltrials.gov/ct2/show/NCT04226469.Google Scholar
• Baer AR, Devine S, Beardmore CD, Catalano R (2011) Clinical investigator responsibilities. J. Oncol. Pract. 7(2):124–128.Crossref, Google Scholar
• Bellos I, Kavadias S (2021) Service design for a holistic customer experience: A process framework. Management Sci. 67(3):1718–1736.Link, Google Scholar
• Bertsimas D, Sturt B (2020) Computation of exact bootstrap confidence intervals: Complexity and deterministic algorithms. Oper. Res. 68(3):949–964.Link, Google Scholar
• Booker CL, Harding S, Benzeval M (2011) A systematic review of the effect of retention methods in population-based cohort studies. BMC Public Health 11(1):1–12.Crossref, Google Scholar
• Bradbury M (2019) A study of a device used to take pictures of skin blood flow. Accessed February 5, 2026, https://clinicaltrials.gov/ct2/show/NCT03912376.Google Scholar
• Brøgger-Mikkelsen M, Zibert JR, Andersen AD, Lassen U, Hædersdal M, Ali Z, Thomsen SF (2022) Changes in key recruitment performance metrics from 2008–2019 in industry-sponsored phase. clinical trials registered at clinicaltrials.gov. PLoS One 17(7):1–15.Crossref, Google Scholar
• Canadian Agency for Drugs and Technologies in Health (2024) Sotorasib (lumakras): Cadth reimbursement recommendation: Indication: For the treatment of adult patients with kirsten rat sarcoma viral oncogene homologue (kras) g12c-mutated locally advanced (not amenable to curative therapy) or metastatic non–Small cell lung cancer (nsclc) who have received at least one prior systemic therapy. Accessed February 5, 2026, https://www.ncbi.nlm.nih.gov/books/NBK602922/.Google Scholar
• Chen N, Khademi A (2024) Adaptive seamless dose-finding trials. Manufacturing Service Oper. Management 26(5):1656–1673.Google Scholar
• Chhatre S, Jefferson A, Cook R, Meeker CR, Kim JH, Hartz KM, Wong YN, et al. (2018) Patient-centered recruitment and retention for a randomized controlled study. Trials 19(1):1–10.Crossref, Google Scholar
• Chiofalo B (2023) Endometrial changes in breast cancer women. Accessed February 5, 2026, https://clinicaltrials.gov/ct2/show/NCT05717634.Google Scholar
• CISCRP (2021) Perceptions and insights study. Accessed February 5, 2026, https://www.ciscrp.org/wp-content/uploads/2021/11/2021-PI-ALL.pdf.Google Scholar
• ClinicalTrials.gov (2020) Learn about clinical studies. Accessed February 5, 2026, https://clinicaltrials.gov/ct2/about-studies/learn.Google Scholar
• Colvin M, Maravelias CT (2010) Modeling methods and a branch and cut algorithm for pharmaceutical clinical trial planning using stochastic programming. Eur. J. Oper. Res. 203(1):205–215.Crossref, Google Scholar
• Corbett CJ, DeCroix GA (2001) Shared-savings contracts for indirect materials in supply chains: Channel profits and environmental impacts. Management Sci. 47(7):881–893.Link, Google Scholar
• Dey D, Fan M, Zhang C (2010) Design and analysis of contracts for software outsourcing. Inform. Systems Res. 21(1):93–114.Link, Google Scholar
• Drago R, Garvey GT, Turnbull GK (1996) A collective tournament. Econom. Lett. 50(2):223–227.Crossref, Google Scholar
• ElectroCore INC (2019) Vagus nerve stimulation for management of bronchoconstriction in patients hospitalized with COPD exacerbations. Accessed February 5, 2026, https://clinicaltrials.gov/ct2/show/NCT01612793.Google Scholar
• Emanuel EJ, Schnipper LE, Kamin DY, Levinson J, Lichter AS (2003) The costs of conducting clinical research. J. Clinical Oncol. 21(22):4145–4150.Crossref, Google Scholar
• Evangelista E (2013) Patient recruitment: The most recognized silent driver of clinical development costs. Internat. Pharmaceutical Indust. 5(1):64–66.Google Scholar
• Feehan AK, Garcia-Diaz J (2020) Investigator responsibilities in clinical research. Ochsner J. 20(1):44–49.Crossref, Google Scholar
• Feng T, Ren ZJ, Zhang F (2019) Service outsourcing: Capacity, quality and correlated costs. Production Oper. Management 28(3):682–699.Crossref, Google Scholar
• Fleischhacker AJ, Zhao Y (2011) Planning for demand failure: A dynamic lot size model for clinical trial supply chains. Eur. J. Oper. Res. 211(3):496–506.Crossref, Google Scholar
• Fleischhacker A, Ninh A, Zhao Y (2015) Positioning inventory in clinical trial supply chains. Production Oper. Management 24(6):991–1011.Crossref, Google Scholar
• Fouad MN, Johnson RE, Nagy MC, Person SD, Partridge EE (2014) Adherence and retention in clinical trials: A community-based approach. Cancer 120(S7):1106–1112.Crossref, Google Scholar
• Genesis Research Services (2021) Clinical trials—The role of the coordinator. Accessed February 5, 2026, https://genesisresearchservices.com/clinical-trials-the-role-of-the-coordinator/.Google Scholar
• Ghamat S, Zaric GS, Pun H (2021) Care-coordination: Gain-sharing agreements in bundled payment models. Production Oper. Management 30(5):1457–1474.Crossref, Google Scholar
• Goh J, Bayati M, Zenios SA, Singh S, Moore D (2018) Data uncertainty in markov chains: Application to cost-effectiveness analyses of medical innovations. Oper. Res. 66(3):697–715.Link, Google Scholar
• Gresham GK, Ehrhardt S, Meinert JL, Appel LJ, Meinert CL (2018) Characteristics and trends of clinical trials funded by the national institutes of health between 2005 and 2015. Clinical Trials 15(1):65–74.Crossref, Google Scholar
• Guillen P, Merrett D, Slonim R (2015) A new solution for the moral hazard problem in team production. Manageement Sci. 61(7):1514–1530.Link, Google Scholar
• Gupta S, Agrawal A, Ryan JK (2023) Agile contracting: Managing incentives under uncertain needs. Production Oper. Management 32(3):972–988.Crossref, Google Scholar
• Gupta D, Mehrotra M, Tang X (2021) Gainsharing contracts for CMS’ episode-based payment models. Production Oper. Management 30(5):1290–1312.Crossref, Google Scholar
• Hasija S, Pinker EJ, Shumsky RA (2008) Call center outsourcing contracts under information asymmetry. Management Sci. 54(4):793–807.Link, Google Scholar
• Hauser JR, Simester DI, Wernerfelt B (1994) Customer satisfaction incentives. Marketing Sci. 13(4):327–350.Link, Google Scholar
• Henderson KH, Helmkamp LJ, Steiner JF, Havranek EP, Vupputuri SX, Hanratty R, Blair IV, Maertens JA, Dickinson M, Daugherty SL (2022) Relationship between social vulnerability indicators and trial participant attrition: Findings from the hyvalue trial. Circ. Cardiovasc. Qual. Outcomes 15(5):e007709.Crossref, Google Scholar
• HHS.gov (2019) Attachment A—Addressing ethical concerns offers of payment to research participants. Accessed February 5, 2026, https://www.hhs.gov/ohrp/sachrp-committee/recommendations/attachment-a-september-30-2019/index.html.Google Scholar
• Holmstrom B (1982) Moral hazard in teams. Bell J. Econom. 13(2):324–340.Crossref, Google Scholar
• Hu Y, Shin J, Tang Z (2016) Incentive problems in performance-based online advertising pricing: Cost per click vs. cost per action. Management Sci. 62(7):2022–2038.Link, Google Scholar
• Hunsley J (2020) An online post-adoption family intervention using trust-based relational intervention (TBRI) to improve understanding, well-being, and connection in adoptive families. Identifier NCT04443504, Accessed February 5, 2026, https://clinicaltrials.gov/ct2/show/NCT04443504.Google Scholar
• Ingram M (2021a) Combine compensation models for more precise investigator payments. Accessed February 5, 2026, https://cms.centerwatch.com/articles/25827-combine-compensation-models-for-more-precise-investigator-payments.Google Scholar
• Ingram M (2021b) Methods for calculating PI compensation: Pros and cons. https://cms.centerwatch.com/articles/25818-methods-for-calculating-pi-compensation-pros-and-cons.Google Scholar
• Institute of Medicine (2015) Sharing Clinical Trial Data (National Academies Press, Washington, DC).Google Scholar
• Istanbul Medipol University Hospital (2019) Use modular medical equipment vehicle in mobilization of patient with chest tube. Accessed February 5, 2026, https://clinicaltrials.gov/study/NCT05081856.Google Scholar
• Jain N, Hasija S, Popescu DG (2013) Optimal contracts for outsourcing of repair and restoration services. Oper. Res. 61(6):1295–1311.Link, Google Scholar
• Janssen (2021) A study of Ad26.COV2.S and influenza vaccines in healthy adults. Accessed February 5, 2026, https://clinicaltrials.gov/ct2/show/NCT05091307.Google Scholar
• Jiang H, Pang Z, Savin S (2012) Performance-based contracts for outpatient medical services. Manufacturing Service Oper. Management 14(4):654–669.Link, Google Scholar
• Konopnicki D (2018) Vaccination against human papillomavirus (HPV) with the 9-valent vaccine in HIV-positive women (the papillon study) (papillon). https://clinicaltrials.gov/ct2/show/NCT03391921.Google Scholar
• Kouvelis P, Milner J, Tian Z (2017) Clinical trials for new drug development: Optimal investment and application. Manufacturing Service Oper. Management 19(3):437–452.Link, Google Scholar
• Lafontaine F, Slade ME (1996) Retail contracting and costly monitoring: Theory and evidence. Eur. Econom. Rev. 40(3–5):923–932.Crossref, Google Scholar
• Lin RSY (2021) Effects of an empowerment-based psycho-behavioral program on persons with mild cognitive impairment. Identifier NCT04723667, Accessed February 5, 2026, https://clinicaltrials.gov/ct2/show/NCT04723667.Google Scholar
• Lutgendorf S (2019) Biobehavioral-cytokine interactions in ovarian cancer (VEGF). Identifier NCT01113112, Accessed February 5, 2026, https://clinicaltrials.gov/ct2/show/NCT01113112.Google Scholar
• Mayo Clinic (2011) Improving venous thromboembolism prophylaxis. Accessed February 5, 2026, https://clinicaltrials.gov/ct2/show/NCT01304108.Google Scholar
• McAfee RP, McMillan J (1991) Optimal contracts for teams. Internat. Econom. Rev. (Philadelphia) 32(3):561–577.Crossref, Google Scholar
• McCabe C (2020) Clinical investigation of the dextenza 0.4mg intracanalicular insert delivery system used in cataract surgery. Identifier NCT04687800, Accessed February 5, 2026, https://clinicaltrials.gov/ct2/show/NCT04687800.Google Scholar
• mdgroup (2020) Why do patients drop out of clinical trials? Accessed February 5, 2026, https://mdgroup.com/blog/why-do-patients-drop-out-of-clinical-trials/.Google Scholar
• Milgrom P, Roberts J (1995) Complementarities and fit strategy, structure, and organizational change in manufacturing. J. Accounting Econom. 19(2–3):179–208.Crossref, Google Scholar
• Mookherjee D (2006) Decentralization, hierarchies, and incentives: A mechanism design perspective. J. Econom. Lit. 44(2):367–390.Crossref, Google Scholar
• Moore TJ, Heyward J, Anderson G, Alexander GC (2020) Variation in the estimated costs of pivotal clinical benefit trials supporting the us approval of new therapeutic agents, 2015–2017: A cross-sectional study. BMJ Open 10(6):e038863.Crossref, Google Scholar
• Myerson RB (1981) Optimal auction design. Math. Oper. Res. 6(1):58–73.Link, Google Scholar
• National Research Council (2010) The Prevention and Treatment of Missing Data in Clinical Trials (National Academies Press, Washington, DC).Google Scholar
• NIH Office of Biotechnology Activities (2018) Requirements for DAIDS-supported research involving recombinant DNA. Accessed February 5, 2026, https://rsc.niaid.nih.gov/sites/default/files/IBCReqsRecombinantDNA.pdf.Google Scholar
• Nuttall A (2012) Considerations for improving patient recruitment into clinical trials. Accessed February 5, 2026, https://www.clinicalleader.com/doc/considerations-for-improving-patient-0001.Google Scholar
• Office of Biotechnology Activities Oversight (2023) Clinical trials and the IBC. Accessed February 5, 2026, https://research.umn.edu/units/obao/research-oversight-areas/clinical-trials-and-ibc.Google Scholar
• Office of Institutional Compliance (2021) Fixed price contracts, including clinical trials. Accessed February 5, 2026, https://policy.umn.edu/research/clinicaltrials.Google Scholar
• Parkinson B, Meacock R, Sutton M, Fichera E, Mills N, Shorter GW, Treweek S, et al. (2019) Designing and using incentives to support recruitment and retention in clinical trials: A scoping review and a checklist for design. Trials 20(1):1–14.Crossref, Google Scholar
• Pfizer (2011) Pfizer announces new strategic partnerships with Icon and Parexel International Corporation. Accessed February 5, 2026, https://www.pfizer.com/news/press-release/press-release-detail/pfizer_announces_new_strategic_partnerships_with_icon_and_parexel_international_corporation.Google Scholar
• Pfizer (2016) Pfizer New Haven Clinical Research Unit. Accessed February 5, 2026, https://www.pfizer.com/research/clinical_trials/new_haven_cru.Google Scholar
• Rajagopalan S, Tong C (2022) Payment models to coordinate healthcare providers with partial attribution of outcome costs. Manufacturing Service Oper. Management 24(1):600–616.Link, Google Scholar
• Roels G (2014) Optimal design of coproductive services: Interaction and work allocation. Manufacturing Service Oper. Management 16(4):578–594.Link, Google Scholar
• Schleider J (2021) Evaluating the telehealth single session consultation service. Identifier NCT04725578, Accessed February 5, 2026, https://clinicaltrials.gov/ct2/show/NCT04725578.Google Scholar
• Song X, Mehrotra M, Rajapakshe T (2023) An analysis of incentive schemes for participant retention in clinical studies. Manufacturing Service Oper. Management 25(3):1033–1050.Link, Google Scholar
• Spinner J (2021) Cros fighting for the future of clinical research: Report. Accessed February 5, 2026, https://www.outsourcing-pharma.com/Article/2021/03/29/CROs-fighting-for-the-future-of-clinical-research-report.Google Scholar
• Swanson G (2020) Circadian misalignment in inflammatory bowel disease. Identifier NCT04637399, Accessed February 5, 2026, https://clinicaltrials.gov/ct2/show/NCT04637399.Google Scholar
• Tian Z, Han W, Powell WB (2021) Adaptive learning of drug quality and optimization of patient recruitment for clinical trials with dropouts. Manufacturing Service Oper. Management 24(1):580–599.Link, Google Scholar
• Tian Z, Hazen GB, Li H (2023) Optimal enrollment in late-stage new drug development with learning of drug’s efficacy for group-sequential clinical trials. Manufacturing Service Oper. Management 25(1):88–107.Link, Google Scholar
• Tucker R (2021) Evaluation of sleep program. Identifier NCT04727619, https://clinicaltrials.gov/ct2/show/NCT04727619.Google Scholar
• UCSF (2022) A study of long-term al001 dosing in frontotemporal dementia (FTD) patients (INFRONT-2). Accessed February 5, 2026, https://memory.ucsf.edu/research-trials/clinical-trials/infront-2.Google Scholar
• U.S. FDA (2018) Payment and reimbursement to research subjects: Guidance for institutional review boards and clinical investigators. Accessed February 5, 2026, https://www.fda.gov/regulatory-information/search-fda-guidance-documents/payment-and-reimbursement-research-subjects.Google Scholar
• Wong HH, Jessup A, Sertkaya A, Birkenbach A, Berlind A, Eyraud J (2014) Examination of clinical trial costs and barriers for drug development final. Accessed February 5, 2026, https://aspe.hhs.gov/report/examination-clinical-trial-costs-and-barriers-drug-development.Google Scholar
• Zhang H, Kong G, Rajagopalan S (2018) Contract design by service providers with private effort. Management Sci. 64(6):2672–2689.Link, Google Scholar